Tern Wyld Networks warrant exercise

Tern Plc (LON:TERN), the company focused on value creation from Internet of Things technology businesses, has announced that it has committed to exercise the 320,454 TO1 Warrants in Wyld Networks AB which represents all of the TO1 Warrants that were issued to Tern pursuant to its investment as part of Wyld Networks’ Offering in conjunction with Wyld Networks’ IPO and admission to trading on the NASDAQ First North Growth Market in Stockholm on 2 July 2021.

Tern will pay SEK 3,605,108 (approximately £290,000) to exercise its TO1 Warrants to subscribe for 320,454 shares in Wyld Networks at SEK 11.25 per share, and this will be funded from Tern’s existing cash resources.

Prior to the completion of the TO1 Warrant exercises Tern held 58.7% of Wyld Networks’ issued share capital.  The subscription period for the in aggregate, 2,275,000 TO1 Warrants commenced on 22 March 2022 and will end on 4 April 2022.  If all of the TO1 Warrants are exercised Tern’s holding in Wyld Networks will reduce to 49.1% and a further announcement regarding Tern’s resultant holding in Wyld Networks will be made when the exercise period for the TO1 Warrants is completed.

Wyld Networks is a virtual satellite network operator that develops and delivers innovative wireless technology solutions that enable affordable connectivity for IoT devices and sensors anywhere in the world – especially for the 85% of the world’s surface where there are no cellular networks.  For the year ended 31 December 2020, Wyld Networks’ audited loss for the year was SEK 9,536,000 (2019: loss of SEK 6,602,000) on net sales of SEK 2,475,000 (2019: SEK 1,559,000) and its audited total assets as at 31 March 2020 were SEK 5,752,000 (31 December 2019: SEK 5,636,000).

Capitalised terms not otherwise defined herein have the same meaning as in the Tern plc announcement “Proposed IPO of Wyld Networks” made on 9 June 2021.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn

    More articles like this

    Tern plc

    Addressing security vulnerabilities in IoT ecosystems

    Security issues in IoT are a pressing concern as the number of connected devices skyrockets. What vulnerabilities are these devices exposed to, and what can be done to secure them against escalating cyber threats? This article

    Tern plc

    FundamentalVR welcomes Carlos de Torres Gimeno to the Board

    Global leader in immersive surgical training FundamentalVR has announced the appointment of Carlos de Torres Gimeno to its board of directors. With an impressive background in global technology leadership, De Torres brings a wealth of experience and strategic

    Tern plc

    Revolutionising Healthcare Marketing with patient-centric data science

    Healthcare Marketing Revolution: Embracing Patient-Centric Strategies with Advanced Data Science In the fast-changing realm of Healthcare Marketing, innovation is the driving force behind building strong connections with your target audience. Thanks to advancements in technology, particularly

    Tern plc

    Top 10 IoT trends predicted by Tern for 2024

    Here are Tern’s predictions for the top ten IoT trends we’ll see this year: 1. Continued growth in the number of connected devices It hardly requires a crystal ball to predict that the number of connected

    Tern plc

    Device Authority secures $7M funding for Enterprise IoT security

    Device Authority, a global leader in Identity and Access Management for Enterprise IoT ecosystems, announced $7M in Series A funding from Ten Eleven Ventures, a global venture capital firm specializing in cybersecurity. The investment follows Device Authority’s prestigious Microsoft

    Tern plc

    How Artificial Intelligence is reshaping healthcare

    2023 was a big year for artificial intelligence (AI). The launch of Chat-GPT-4, Microsoft Copilot, Google Bard and Amazon Q has raised awareness of the potential of AI solutions across the board. In the healthcare sector, the

    Tern plc

    Uncovering insights on GLP-1 and GIP/GLP-1 medications

    In collaboration with our partners at Sermo, our Advanced Data Science and Artificial Intelligence solutions played a crucial role in uncovering previously unseen intelligence about GLP-1 and GIP/GLP-1. This report is designed to comprehend challenges, perceptions,